| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.815 | 0.003 | 0.815 | Alcohol oxidase inhibitor | 0.126 0.013 CID_69607982 | ||
| 0.804 | 0.004 | 0.804 | Aldehyde oxidase inhibitor | 0.17 0.123 CID_69607982 | ||
| 0.726 | 0.003 | 0.812 | Alpha-N-acetylglucosaminidase inhibitor | 0.812 0.002 CID_69607982 | CID_69607982 | |
| 0.721 | 0.021 | 0.809 | Caspase 9 stimulant | 0.809 0.01 CID_69607982 | CID_69607982 | |
| 0.684 | 0.008 | 0.684 | 5 Hydroxytryptamine release stimulant | 0.549 0.02 CID_69607982 | ||
| 0.672 | 0.005 | 0.682 | 5 Hydroxytryptamine release inhibitor | 0.682 0.005 CID_69607982 | CID_69607982 | |
| 0.653 | 0.002 | 0.653 | Succinate dehydrogenase inhibitor | 0.255 0.02 CID_69607982 | ||
| 0.646 | 0.013 | 0.876 | Cholesterol antagonist | 0.876 0.003 CID_69607982 | CID_69607982 | |
| 0.608 | 0.006 | 0.608 | Superoxide dismutase inhibitor | |||
| 0.588 | 0.009 | 0.588 | GABA C receptor rho-3 antagonist | |||
| 0.581 | 0.012 | 0.808 | Histamine release inhibitor | 0.808 0.003 CID_69607982 | CID_69607982 | |
| 0.575 | 0.014 | 0.722 | Immunomodulator | 0.722 0.005 CID_69607982 | CID_69607982 | |
| 0.564 | 0.004 | 0.564 | Aldehyde dehydrogenase inhibitor | 0.363 0.007 CID_69607982 | ||
| 0.552 | 0.005 | 0.676 | Anesthetic general | 0.676 0.004 CID_69607982 | CID_69607982 | |
| 0.555 | 0.02 | 0.702 | Vasodilator, peripheral | 0.702 0.006 CID_69607982 | CID_69607982 | |
| 0.524 | 0.008 | 0.524 | Peroxidase inhibitor | |||
| 0.538 | 0.023 | 0.63 | Immunosuppressant | 0.63 0.01 CID_69607982 | CID_69607982 | |
| 0.484 | 0.006 | 0.484 | Phospholipase C inhibitor | 0.43 0.009 CID_69607982 | ||
| 0.481 | 0.018 | 0.786 | Vasodilator, coronary | 0.786 0.004 CID_69607982 | CID_69607982 | |
| 0.463 | 0.014 | 0.875 | Angiogenesis stimulant | 0.875 0.003 CID_69607982 | CID_69607982 | |
| 0.462 | 0.013 | 0.599 | Interleukin 2 agonist | 0.599 0.004 CID_69607982 | CID_69607982 | |
| 0.458 | 0.016 | 0.504 | Hypolipemic | 0.504 0.012 CID_69607982 | CID_69607982 | |
| 0.45 | 0.016 | 0.45 | Psychostimulant | 0.319 0.038 CID_69607982 | ||
| 0.43 | 0.009 | 0.43 | 5 Hydroxytryptamine uptake stimulant | 0.186 0.181 CID_69607982 | ||
| 0.422 | 0.006 | 0.422 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.45 | 0.038 | 0.834 | Antithrombotic | 0.834 0.004 CID_69607982 | CID_69607982 | |
| 0.421 | 0.016 | 0.626 | Interleukin agonist | 0.626 0.004 CID_69607982 | CID_69607982 | |
| 0.441 | 0.046 | 0.441 | Toll-Like receptor agonist | 0.213 0.186 CID_69607982 | ||
| 0.395 | 0.009 | 0.443 | Protein kinase stimulant | 0.443 0.006 CID_69607982 | CID_69607982 | |
| 0.405 | 0.021 | 0.521 | DNA synthesis inhibitor | 0.521 0.012 CID_69607982 | CID_69607982 | |
| 0.394 | 0.01 | 0.394 | Bone formation stimulant | 0.162 0.05 CID_69607982 | ||
| 0.389 | 0.005 | 0.389 | GABA C receptor agonist | 0.094 0.073 CID_69607982 | ||
| 0.386 | 0.004 | 0.386 | Ferrochelatase inhibitor | |||
| 0.445 | 0.069 | 0.842 | Cyclophilin D inhibitor | 0.842 0.005 CID_69607982 | CID_69607982 | |
| 0.413 | 0.046 | 0.667 | Immunostimulant | 0.667 0.01 CID_69607982 | CID_69607982 | |
| 0.372 | 0.005 | 0.372 | Neurotrophic factor | 0.179 0.038 CID_69607982 | ||
| 0.371 | 0.004 | 0.512 | Triose-phosphate isomerase inhibitor | 0.512 0.002 CID_69607982 | CID_69607982 | |
| 0.387 | 0.021 | 0.387 | Sodium/bile acid cotransporter inhibitor | 0.297 0.082 CID_69607982 | ||
| 0.403 | 0.039 | 0.548 | Spasmolytic | 0.548 0.018 CID_69607982 | CID_69607982 | |
| 0.367 | 0.005 | 0.367 | Interleukin 4 antagonist | 0.351 0.006 CID_69607982 | ||
| 0.369 | 0.007 | 0.369 | Gastrin inhibitor | 0.3 0.033 CID_69607982 | ||
| 0.387 | 0.025 | 0.573 | Vasodilator | 0.573 0.007 CID_69607982 | CID_69607982 | |
| 0.356 | 0.004 | 0.356 | Ornithine carbamoyltransferase inhibitor | 0.128 0.012 CID_69607982 | ||
| 0.429 | 0.077 | 0.429 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.355 | 0.003 | 0.355 | Creatine kinase inhibitor | 0.114 0.045 CID_69607982 | ||
| 0.38 | 0.031 | 0.541 | Platelet antagonist | 0.541 0.01 CID_69607982 | CID_69607982 | |
| 0.35 | 0.005 | 0.35 | Adenylate kinase inhibitor | 0.328 0.005 CID_69607982 | ||
| 0.345 | 0.005 | 0.345 | Catalase inhibitor | 0.097 0.04 CID_69607982 | ||
| 0.346 | 0.008 | 0.48 | UDP-glucose 4-epimerase inhibitor | 0.48 0.003 CID_69607982 | CID_69607982 | |
| 0.37 | 0.033 | 0.722 | Hypoglycemic | 0.722 0.005 CID_69607982 | CID_69607982 | |
| 0.373 | 0.036 | 0.373 | Calcium channel activator | 0.231 0.17 CID_69607982 | ||
| 0.357 | 0.023 | 0.357 | RNA-directed DNA polymerase inhibitor | 0.288 0.034 CID_69607982 | ||
| 0.34 | 0.01 | 0.34 | Neurotrophic factor enhancer | 0.286 0.022 CID_69607982 | ||
| 0.354 | 0.025 | 0.489 | Cyclic AMP phosphodiesterase inhibitor | 0.489 0.007 CID_69607982 | CID_69607982 | |
| 0.332 | 0.005 | 0.332 | Alcohol dehydrogenase inhibitor | 0.215 0.011 CID_69607982 | ||
| 0.331 | 0.004 | 0.331 | GABA C receptor antagonist | |||
| 0.389 | 0.064 | 0.389 | Toll-Like receptor 7 agonist | |||
| 0.307 | 0.005 | 0.455 | Phosphofructokinase-1 inhibitor | 0.455 0.003 CID_69607982 | CID_69607982 | |
| 0.425 | 0.124 | 0.844 | Antiinflammatory | 0.844 0.01 CID_69607982 | CID_69607982 | |
| 0.319 | 0.019 | 0.433 | Peptidyltransferase inhibitor | 0.433 0.005 CID_69607982 | CID_69607982 | |
| 0.302 | 0.004 | 0.435 | Photosensitizer | 0.435 0.003 CID_69607982 | CID_69607982 | |
| 0.298 | 0.006 | 0.298 | Farnesoid X receptor antagonist | 0.142 0.063 CID_69607982 | ||
| 0.304 | 0.013 | 0.316 | Phospholipase A2 inhibitor | 0.316 0.011 CID_69607982 | CID_69607982 | |
| 0.29 | 0.004 | 0.364 | Interferon agonist | 0.364 0.002 CID_69607982 | CID_69607982 | |
| 0.36 | 0.074 | 0.709 | Transcription factor NF kappa B inhibitor | 0.709 0.019 CID_69607982 | CID_69607982 | |
| 0.287 | 0.005 | 0.287 | Carbamoyl phosphate synthetase inhibitor | 0.136 0.013 CID_69607982 | ||
| 0.294 | 0.013 | 0.294 | Anesthetic local | |||
| 0.361 | 0.081 | 0.361 | Calpain 2 inhibitor | |||
| 0.277 | 0.003 | 0.277 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.295 | 0.021 | 0.525 | Interferon gamma antagonist | 0.525 0.005 CID_69607982 | CID_69607982 | |
| 0.296 | 0.022 | 0.296 | Lipocortins synthesis antagonist | 0.22 0.045 CID_69607982 | ||
| 0.366 | 0.093 | 0.676 | Antibacterial | 0.676 0.011 CID_69607982 | CID_69607982 | |
| 0.295 | 0.029 | 0.53 | Non-steroidal antiinflammatory agent | 0.53 0.005 CID_69607982 | CID_69607982 | |
| 0.286 | 0.02 | 0.652 | Amylase inhibitor | 0.652 0.004 CID_69607982 | CID_69607982 | |
| 0.287 | 0.028 | 0.287 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.245 0.045 CID_69607982 | ||
| 0.266 | 0.009 | 0.266 | GABA C receptor rho-2 antagonist | |||
| 0.263 | 0.007 | 0.263 | Toll-Like receptor 2 antagonist | 0.172 0.039 CID_69607982 | ||
| 0.256 | 0.005 | 0.256 | Arachidonic acid antagonist | 0.214 0.021 CID_69607982 | ||
| 0.274 | 0.023 | 0.387 | Lipid peroxidase inhibitor | 0.387 0.01 CID_69607982 | CID_69607982 | |
| 0.272 | 0.024 | 0.272 | Insulin sensitizer | 0.262 0.028 CID_69607982 | ||
| 0.285 | 0.039 | 0.524 | Platelet adhesion inhibitor | 0.524 0.005 CID_69607982 | CID_69607982 | |
| 0.25 | 0.005 | 0.25 | Interleukin 5 antagonist | 0.113 0.029 CID_69607982 | ||
| 0.301 | 0.056 | 0.462 | DNA damaging | 0.462 0.018 CID_69607982 | CID_69607982 | |
| 0.249 | 0.005 | 0.249 | MAP3K9 inhibitor | |||
| 0.318 | 0.074 | 0.615 | Apoptosis antagonist | 0.615 0.008 CID_69607982 | CID_69607982 | |
| 0.251 | 0.008 | 0.251 | Porphobilinogen synthase inhibitor | |||
| 0.258 | 0.016 | 0.347 | DNA polymerase I inhibitor | 0.347 0.008 CID_69607982 | CID_69607982 | |
| 0.245 | 0.004 | 0.245 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.245 | 0.004 | 0.245 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.244 | 0.005 | 0.244 | GABA C receptor rho-1 antagonist | |||
| 0.256 | 0.017 | 0.256 | Cholesterol synthesis inhibitor | 0.204 0.026 CID_69607982 | ||
| 0.278 | 0.041 | 0.278 | Platelet aggregation inhibitor | 0.191 0.088 CID_69607982 | ||
| 0.245 | 0.01 | 0.275 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.275 0.008 CID_69607982 | CID_69607982 | |
| 0.24 | 0.006 | 0.24 | Vanilloid 1 agonist | 0.225 0.007 CID_69607982 | ||
| 0.237 | 0.003 | 0.237 | Acyl-CoA dehydrogenase inhibitor | 0.172 0.007 CID_69607982 | ||
| 0.239 | 0.005 | 0.239 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.237 | 0.005 | 0.237 | Sphingomyelinase inhibitor | 0.222 0.006 CID_69607982 | ||
| 0.251 | 0.019 | 0.389 | Insulin secretagoues | 0.389 0.007 CID_69607982 | CID_69607982 | |
| 0.243 | 0.014 | 0.243 | Aminopeptidase B inhibitor | 0.083 0.078 CID_69607982 | ||
| 0.291 | 0.064 | 0.291 | Insulysin inhibitor | |||
| 0.233 | 0.009 | 0.502 | NADH dehydrogenase inhibitor | 0.502 0.003 CID_69607982 | CID_69607982 | |
| 0.228 | 0.005 | 0.228 | Adenylate cyclase stimulant | 0.189 0.019 CID_69607982 | ||
| 0.228 | 0.006 | 0.228 | Electron transport complex I inhibitor | |||
| 0.238 | 0.017 | 0.308 | ATPase inhibitor | 0.308 0.005 CID_69607982 | CID_69607982 | |
| 0.225 | 0.006 | 0.225 | Argininosuccinate synthase inhibitor | 0.162 0.01 CID_69607982 | ||
| 0.222 | 0.004 | 0.222 | Glycine receptor agonist | 0.206 0.004 CID_69607982 | ||
| 0.22 | 0.002 | 0.228 | Ca2+-transporting ATPase inhibitor | 0.228 0.002 CID_69607982 | CID_69607982 | |
| 0.221 | 0.006 | 0.221 | Electrolyte absorption antagonist | |||
| 0.282 | 0.069 | 0.699 | Antioxidant | 0.699 0.006 CID_69607982 | CID_69607982 | |
| 0.223 | 0.009 | 0.223 | Mucolytic | 0.199 0.013 CID_69607982 | ||
| 0.247 | 0.034 | 0.247 | Nitric-oxide synthase stimulant | 0.233 0.046 CID_69607982 | ||
| 0.215 | 0.003 | 0.293 | Interferon inducer | 0.293 0.002 CID_69607982 | CID_69607982 | |
| 0.231 | 0.02 | 0.385 | Cell wall synthesis inhibitor | 0.385 0.007 CID_69607982 | CID_69607982 | |
| 0.231 | 0.021 | 0.231 | Toll-Like receptor antagonist | |||
| 0.287 | 0.078 | 0.287 | Lipoxygenase inhibitor | |||
| 0.234 | 0.025 | 0.234 | Nav1.2 sodium channel blocker | |||
| 0.235 | 0.026 | 0.235 | Interleukin 6 antagonist | 0.206 0.037 CID_69607982 | ||
| 0.215 | 0.007 | 0.215 | Keratolytic | |||
| 0.219 | 0.013 | 0.219 | Carbonic anhydrase III inhibitor | 0.166 0.023 CID_69607982 | ||
| 0.221 | 0.016 | 0.403 | Expectorant | 0.403 0.005 CID_69607982 | CID_69607982 | |
| 0.21 | 0.006 | 0.21 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.206 | 0.003 | 0.206 | Sphingosine kinase inhibitor | 0.063 0.035 CID_69607982 | ||
| 0.207 | 0.004 | 0.207 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.206 | 0.003 | 0.462 | Alpha-mannosidase inhibitor | 0.462 0.001 CID_69607982 | CID_69607982 | |
| 0.239 | 0.037 | 0.384 | Thrombolytic | 0.384 0.013 CID_69607982 | CID_69607982 | |
| 0.209 | 0.007 | 0.209 | Prolactin inhibitor | |||
| 0.221 | 0.021 | 0.504 | Alkylator | 0.504 0.005 CID_69607982 | CID_69607982 | |
| 0.205 | 0.007 | 0.205 | Vanilloid agonist | 0.093 0.042 CID_69607982 | ||
| 0.212 | 0.015 | 0.496 | Cyclooxygenase 3 inhibitor | 0.496 0.003 CID_69607982 | CID_69607982 | |
| 0.328 | 0.134 | 0.328 | Calcium channel L-type activator | |||
| 0.228 | 0.035 | 0.304 | Diuretic | 0.304 0.022 CID_69607982 | CID_69607982 | |
| 0.199 | 0.007 | 0.199 | Glutamate decarboxylase inhibitor | |||
| 0.205 | 0.017 | 0.205 | Bronchodilator | |||
| 0.205 | 0.018 | 0.205 | Nav1.1 sodium channel blocker | |||
| 0.189 | 0.005 | 0.238 | Acetylcholine release stimulant | 0.238 0.004 CID_69607982 | CID_69607982 | |
| 0.186 | 0.003 | 0.186 | Estrogen-related receptor beta agonist | |||
| 0.218 | 0.035 | 0.32 | Melanin inhibitor | 0.32 0.019 CID_69607982 | CID_69607982 | |
| 0.186 | 0.003 | 0.186 | Sphingosine kinase 2 inhibitor | |||
| 0.216 | 0.034 | 0.216 | Thiol protease inhibitor | |||
| 0.332 | 0.15 | 0.713 | Apoptosis agonist | 0.713 0.028 CID_69607982 | CID_69607982 | |
| 0.187 | 0.006 | 0.187 | Glutathione S-transferase inhibitor | 0.084 0.054 CID_69607982 | ||
| 0.258 | 0.077 | 0.258 | Cardiotonic | |||
| 0.218 | 0.038 | 0.218 | Antipruritic | |||
| 0.197 | 0.019 | 0.197 | Carbonic anhydrase XV inhibitor | |||
| 0.217 | 0.04 | 0.217 | Cytidine deaminase inhibitor | |||
| 0.217 | 0.039 | 0.217 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.187 | 0.011 | 0.187 | Glutamate dehydrogenase inhibitor | 0.131 0.019 CID_69607982 | ||
| 0.178 | 0.003 | 0.456 | Mannosidase inhibitor | 0.456 0.001 CID_69607982 | CID_69607982 | |
| 0.18 | 0.005 | 0.195 | Neuraminidase (influenza) inhibitor | 0.195 0.005 CID_69607982 | CID_69607982 | |
| 0.187 | 0.015 | 0.187 | Gastric antisecretory | |||
| 0.196 | 0.024 | 0.199 | CF transmembrane conductance regulator agonist | 0.199 0.022 CID_69607982 | CID_69607982 | |
| 0.193 | 0.021 | 0.242 | Microtubule formation inhibitor | 0.242 0.011 CID_69607982 | CID_69607982 | |
| 0.237 | 0.069 | 0.237 | Neuropeptide Y2 antagonist | |||
| 0.172 | 0.004 | 0.172 | Glucosylceramidase inhibitor | 0.155 0.004 CID_69607982 | ||
| 0.175 | 0.007 | 0.175 | Biliverdin reductase inhibitor | 0.111 0.016 CID_69607982 | ||
| 0.191 | 0.024 | 0.191 | Antibacterial (Helicobacter pylori) | 0.174 0.031 CID_69607982 | ||
| 0.169 | 0.002 | 0.222 | Glucose-6-phosphate isomerase inhibitor | 0.222 0.001 CID_69607982 | CID_69607982 | |
| 0.188 | 0.021 | 0.188 | Falcipain 3 inhibitor | |||
| 0.206 | 0.04 | 0.206 | Acetylcholine M1 receptor antagonist | |||
| 0.169 | 0.004 | 0.169 | GABA B receptor agonist | |||
| 0.167 | 0.003 | 0.167 | Sphingosine kinase 1 inhibitor | 0.04 0.031 CID_69607982 | ||
| 0.181 | 0.018 | 0.181 | Pregnane X receptor agonist | |||
| 0.172 | 0.009 | 0.172 | Aminopeptidase I inhibitor | |||
| 0.19 | 0.028 | 0.19 | Adenylate cyclase inhibitor | 0.113 0.073 CID_69607982 | ||
| 0.169 | 0.008 | 0.169 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.164 0.008 CID_69607982 | ||
| 0.176 | 0.017 | 0.176 | Calcium antagonist | |||
| 0.169 | 0.009 | 0.197 | Toll-Like receptor 2 agonist | 0.197 0.007 CID_69607982 | CID_69607982 | |
| 0.237 | 0.078 | 0.237 | Calpain inhibitor | |||
| 0.177 | 0.019 | 0.543 | Mediator release inhibitor | 0.543 0.004 CID_69607982 | CID_69607982 | |
| 0.166 | 0.008 | 0.166 | Ornithine decarboxylase inhibitor | 0.126 0.021 CID_69607982 | ||
| 0.184 | 0.028 | 0.184 | Cathepsin H inhibitor | |||
| 0.158 | 0.002 | 0.158 | Estrogen-related receptor beta antagonist | |||
| 0.183 | 0.026 | 0.183 | Nav1.6 sodium channel blocker | |||
| 0.16 | 0.005 | 0.16 | Neuraminidase inhibitor | 0.159 0.005 CID_69607982 | ||
| 0.19 | 0.036 | 0.219 | Mannose-6-phosphate isomerase inhibitor | 0.219 0.021 CID_69607982 | CID_69607982 | |
| 0.184 | 0.03 | 0.184 | Nav1.3 sodium channel blocker | |||
| 0.165 | 0.011 | 0.165 | Anabolic | 0.13 0.031 CID_69607982 | ||
| 0.211 | 0.059 | 0.607 | Hepatoprotectant | 0.607 0.004 CID_69607982 | CID_69607982 | |
| 0.166 | 0.014 | 0.245 | Toll-Like receptor 4 antagonist | 0.245 0.004 CID_69607982 | CID_69607982 | |
| 0.165 | 0.015 | 0.165 | DOPA decarboxylase inhibitor | |||
| 0.172 | 0.023 | 0.172 | Interleukin 8 antagonist | |||
| 0.186 | 0.037 | 0.581 | Monophenol monooxygenase inhibitor | 0.581 0.005 CID_69607982 | CID_69607982 | |
| 0.157 | 0.009 | 0.157 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.189 | 0.042 | 0.189 | Neurotensin receptor agonist | |||
| 0.217 | 0.071 | 0.217 | MAP kinase kinase 2 inhibitor | |||
| 0.175 | 0.031 | 0.175 | Cystathionine beta-synthase inhibitor | 0.127 0.053 CID_69607982 | ||
| 0.172 | 0.03 | 0.172 | Chelator | |||
| 0.163 | 0.021 | 0.163 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.2 | 0.057 | 0.2 | Amyloid beta precursor protein antagonist | |||
| 0.164 | 0.023 | 0.164 | TRPA1 agonist | 0.102 0.083 CID_69607982 | ||
| 0.144 | 0.004 | 0.144 | Squalene epoxidase inhibitor | 0.101 0.005 CID_69607982 | ||
| 0.152 | 0.012 | 0.152 | Peroxisome proliferator-activated receptor gamma agonist | 0.091 0.033 CID_69607982 | ||
| 0.142 | 0.004 | 0.142 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.162 | 0.025 | 0.162 | Protein kinase C gamma inhibitor | 0.101 0.074 CID_69607982 | ||
| 0.18 | 0.042 | 0.439 | Hemostatic | 0.439 0.006 CID_69607982 | CID_69607982 | |
| 0.147 | 0.01 | 0.147 | Cannabinoid CB1 receptor agonist | |||
| 0.142 | 0.007 | 0.142 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.14 | 0.004 | 0.14 | Glutamate (mGluR6) antagonist | 0.081 0.023 CID_69607982 | ||
| 0.139 | 0.005 | 0.139 | Aconitate hydratase inhibitor | |||
| 0.15 | 0.017 | 0.15 | ABCA1 expression enhancer | |||
| 0.254 | 0.121 | 0.254 | Thyroid hormone antagonist | |||
| 0.141 | 0.009 | 0.187 | Glycine receptor antagonist | 0.187 0.004 CID_69607982 | CID_69607982 | |
| 0.139 | 0.01 | 0.139 | Bile acid receptor antagonist | 0.104 0.042 CID_69607982 | ||
| 0.179 | 0.05 | 0.215 | Hexokinase inhibitor | 0.215 0.028 CID_69607982 | CID_69607982 | |
| 0.15 | 0.021 | 0.15 | Carbonic anhydrase VI inhibitor | 0.124 0.028 CID_69607982 | ||
| 0.138 | 0.012 | 0.138 | Phosphodiesterase III inhibitor | |||
| 0.133 | 0.007 | 0.133 | Phosphodiesterase 3B inhibitor | |||
| 0.273 | 0.148 | 0.273 | 15-Lipoxygenase inhibitor | |||
| 0.127 | 0.003 | 0.127 | Lysophosphatidic acid 3 receptor antagonist | 0.061 0.021 CID_69607982 | ||
| 0.151 | 0.027 | 0.151 | Caspase 3 inhibitor | |||
| 0.146 | 0.023 | 0.146 | Carbonic anhydrase XIII inhibitor | 0.143 0.023 CID_69607982 | ||
| 0.126 | 0.003 | 0.176 | Cytokine production stimulant | 0.176 0.002 CID_69607982 | CID_69607982 | |
| 0.127 | 0.005 | 0.127 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.156 | 0.034 | 0.156 | Heat shock protein 70 antagonist | 0.147 0.054 CID_69607982 | ||
| 0.157 | 0.035 | 0.157 | 5-Lipoxygenase inhibitor | |||
| 0.15 | 0.029 | 0.39 | AMP-activated protein kinase stimulant | 0.39 0.004 CID_69607982 | CID_69607982 | |
| 0.139 | 0.019 | 0.139 | Macrophage migration inhibitory factor inhibitor | |||
| 0.191 | 0.071 | 0.535 | Nitric oxide antagonist | 0.535 0.013 CID_69607982 | CID_69607982 | |
| 0.128 | 0.008 | 0.128 | Beta 3 adrenoreceptor antagonist | |||
| 0.202 | 0.083 | 0.202 | Interleukin antagonist | |||
| 0.134 | 0.015 | 0.202 | Glutamate release inhibitor | 0.202 0.005 CID_69607982 | CID_69607982 | |
| 0.123 | 0.005 | 0.123 | Phospholipase D inhibitor | |||
| 0.141 | 0.023 | 0.141 | CDC-like kinase 3 inhibitor | |||
| 0.189 | 0.072 | 0.19 | P-glycoprotein inhibitor | 0.19 0.071 CID_69607982 | CID_69607982 | |
| 0.138 | 0.022 | 0.138 | MAP kinase kinase 1 inhibitor | |||
| 0.125 | 0.011 | 0.125 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.119 | 0.006 | 0.119 | Phosphoglycerate kinase inhibitor | 0.041 0.019 CID_69607982 | ||
| 0.135 | 0.022 | 0.135 | Histidine decarboxylase inhibitor | |||
| 0.14 | 0.028 | 0.14 | Estrogen antagonist | |||
| 0.18 | 0.068 | 0.18 | Growth hormone agonist | |||
| 0.132 | 0.02 | 0.524 | Selectin antagonist | 0.524 0.002 CID_69607982 | CID_69607982 | |
| 0.116 | 0.005 | 0.116 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.125 | 0.014 | 0.139 | GABA aminotransferase inhibitor | 0.139 0.01 CID_69607982 | CID_69607982 | |
| 0.119 | 0.009 | 0.119 | Potassium channel (ATP-sensitive) blocker | |||
| 0.128 | 0.019 | 0.244 | Phosphodiesterase 6D inhibitor | 0.244 0.004 CID_69607982 | CID_69607982 | |
| 0.116 | 0.007 | 0.116 | Purinergic P2Y antagonist | 0.102 0.009 CID_69607982 | ||
| 0.205 | 0.096 | 0.467 | Antiamyloidogenic | 0.467 0.019 CID_69607982 | CID_69607982 | |
| 0.133 | 0.024 | 0.133 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.123 | 0.015 | 0.132 | Leukotriene antagonist | 0.132 0.013 CID_69607982 | CID_69607982 | |
| 0.113 | 0.007 | 0.113 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.234 | 0.129 | 0.234 | Thyroid hormone beta antagonist | |||
| 0.114 | 0.009 | 0.114 | Vanilloid 4 agonist | |||
| 0.109 | 0.004 | 0.109 | Purinergic P2Y12 antagonist | 0.043 0.008 CID_69607982 | ||
| 0.121 | 0.017 | 0.121 | mTOR complex 2 inhibitor | |||
| 0.182 | 0.079 | 0.319 | DNA methyltransferase I inhibitor | 0.319 0.02 CID_69607982 | CID_69607982 | |
| 0.106 | 0.005 | 0.106 | Adenosine deaminase inhibitor | 0.095 0.006 CID_69607982 | ||
| 0.108 | 0.008 | 0.108 | MAP kinase kinase 7 inhibitor | |||
| 0.118 | 0.018 | 0.135 | Na+ K+ transporting ATPase inhibitor | 0.135 0.01 CID_69607982 | CID_69607982 | |
| 0.112 | 0.012 | 0.112 | Beta adrenoreceptor antagonist | |||
| 0.104 | 0.005 | 0.104 | Sphingosine 1-phosphate receptor agonist | |||
| 0.112 | 0.013 | 0.112 | Purinergic P2X1 antagonist | 0.074 0.029 CID_69607982 | ||
| 0.103 | 0.006 | 0.103 | MDM2 inhibitor | |||
| 0.117 | 0.019 | 0.117 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.101 | 0.004 | 0.101 | GABA uptake inhibitor | |||
| 0.11 | 0.013 | 0.11 | CDC25B inhibitor | |||
| 0.11 | 0.013 | 0.11 | Cannabinoid CB2 receptor antagonist | |||
| 0.1 | 0.004 | 0.1 | Glutamate (mGluR1a) agonist | |||
| 0.106 | 0.009 | 0.152 | Leukotriene B4 antagonist | 0.152 0.005 CID_69607982 | CID_69607982 | |
| 0.099 | 0.004 | 0.099 | Glutamate (mGluR1) agonist | |||
| 0.123 | 0.028 | 0.123 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.11 | 0.014 | 0.11 | Carbonic anhydrase VB inhibitor | |||
| 0.096 | 0.001 | 0.096 | Lysophosphatidic acid receptor 3 agonist | 0.022 0.005 CID_69607982 | ||
| 0.102 | 0.008 | 0.102 | Potassium channel Kv1.3 blocker | |||
| 0.097 | 0.004 | 0.097 | Neuraminidase (Influenza A) inhibitor | 0.088 0.004 CID_69607982 | ||
| 0.095 | 0.002 | 0.095 | Lysophosphatidic acid receptor 1 agonist | 0.028 0.014 CID_69607982 | ||
| 0.118 | 0.026 | 0.118 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.109 | 0.016 | 0.136 | Phosphodiesterase VI inhibitor | 0.136 0.009 CID_69607982 | CID_69607982 | |
| 0.101 | 0.008 | 0.101 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.124 | 0.032 | 0.124 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.097 | 0.005 | 0.097 | Nicotinic acid receptor agonist | |||
| 0.136 | 0.045 | 0.136 | GABA receptor agonist | |||
| 0.123 | 0.032 | 0.123 | Androgen antagonist | |||
| 0.095 | 0.005 | 0.095 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.131 | 0.042 | 0.3 | Xanthine oxidase inhibitor | 0.3 0.007 CID_69607982 | CID_69607982 | |
| 0.093 | 0.004 | 0.093 | Membrane dipeptidase inhibitor | |||
| 0.102 | 0.013 | 0.102 | Acetyl-CoA transferase inhibitor | |||
| 0.113 | 0.024 | 0.113 | Myeloperoxidase inhibitor | |||
| 0.092 | 0.004 | 0.092 | Geranyltranstransferase inhibitor | |||
| 0.192 | 0.104 | 0.629 | Free radical scavenger | 0.629 0.007 CID_69607982 | CID_69607982 | |
| 0.092 | 0.005 | 0.092 | Adenylate cyclase 1 inhibitor | |||
| 0.115 | 0.028 | 0.115 | Adrenaline agonist | |||
| 0.119 | 0.032 | 0.127 | Thioredoxin inhibitor | 0.127 0.027 CID_69607982 | CID_69607982 | |
| 0.092 | 0.005 | 0.092 | Purinergic P2T antagonist | |||
| 0.097 | 0.011 | 0.097 | Beta 1 adrenoreceptor antagonist | |||
| 0.117 | 0.032 | 0.117 | Histamine N-methyltransferase inhibitor | |||
| 0.109 | 0.023 | 0.109 | Lipase inhibitor | 0.076 0.047 CID_69607982 | ||
| 0.104 | 0.018 | 0.104 | NMDA receptor agonist | |||
| 0.139 | 0.053 | 0.139 | Proteasome inhibitor | |||
| 0.103 | 0.018 | 0.103 | Acetylcholine M5 receptor agonist | |||
| 0.128 | 0.043 | 0.128 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.107 | 0.023 | 0.107 | Estrogen receptor alpha antagonist | |||
| 0.141 | 0.057 | 0.141 | MAP kinase kinase inhibitor | |||
| 0.107 | 0.023 | 0.107 | Cannabinoid receptor agonist | |||
| 0.089 | 0.006 | 0.089 | Prostaglandin agonist | |||
| 0.136 | 0.053 | 0.136 | Acetylcholine muscarinic antagonist | |||
| 0.107 | 0.024 | 0.107 | CDC25A inhibitor | |||
| 0.175 | 0.092 | 0.28 | Amyloid beta aggregation inhibitor | 0.28 0.049 CID_69607982 | CID_69607982 | |
| 0.098 | 0.016 | 0.098 | Xanthine dehydrogenase inhibitor | 0.056 0.041 CID_69607982 | ||
| 0.155 | 0.074 | 0.199 | Protein-tyrosine phosphatase inhibitor | 0.199 0.047 CID_69607982 | CID_69607982 | |
| 0.115 | 0.034 | 0.115 | Toll-Like receptor 3 antagonist | |||
| 0.087 | 0.006 | 0.087 | Fumarate hydratase inhibitor | 0.057 0.011 CID_69607982 | ||
| 0.085 | 0.004 | 0.085 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.035 0.029 CID_69607982 | ||
| 0.085 | 0.005 | 0.085 | Pregnane X receptor antagonist | |||
| 0.097 | 0.018 | 0.097 | NMDA receptor glycine site agonist | |||
| 0.085 | 0.006 | 0.085 | Leukotriene C antagonist | 0.062 0.025 CID_69607982 | ||
| 0.091 | 0.013 | 0.091 | Phosphodiesterase 1C inhibitor | |||
| 0.082 | 0.003 | 0.084 | Uridine phosphorylase inhibitor | 0.084 0.003 CID_69607982 | CID_69607982 | |
| 0.095 | 0.017 | 0.095 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.103 | 0.025 | 0.103 | Leukotriene synthesis inhibitor | |||
| 0.084 | 0.007 | 0.084 | Glutamate (mGluR1a) antagonist | |||
| 0.091 | 0.014 | 0.091 | Glycine transporter 2 inhibitor | |||
| 0.092 | 0.016 | 0.092 | Glutamate (mGluR7) antagonist | |||
| 0.091 | 0.015 | 0.091 | Thromboxane antagonist | |||
| 0.11 | 0.034 | 0.11 | Phosphodiesterase I inhibitor | |||
| 0.116 | 0.04 | 0.216 | Uric acid excretion stimulant | 0.216 0.011 CID_69607982 | CID_69607982 | |
| 0.173 | 0.098 | 0.416 | DNA methylase inhibitor | 0.416 0.01 CID_69607982 | CID_69607982 | |
| 0.081 | 0.005 | 0.112 | Arginase inhibitor | 0.112 0.003 CID_69607982 | CID_69607982 | |
| 0.09 | 0.016 | 0.09 | Prostaglandin F2 alpha antagonist | |||
| 0.089 | 0.015 | 0.1 | Nitric oxide donor | 0.1 0.009 CID_69607982 | CID_69607982 | |
| 0.091 | 0.018 | 0.091 | Antimetabolite | 0.087 0.018 CID_69607982 | ||
| 0.087 | 0.014 | 0.087 | Toll-Like receptor 8 antagonist | |||
| 0.083 | 0.01 | 0.083 | Thromboxane synthase inhibitor | |||
| 0.129 | 0.057 | 0.287 | DNA repair enzyme inhibitor | 0.287 0.004 CID_69607982 | CID_69607982 | |
| 0.087 | 0.015 | 0.087 | Peroxisome proliferator-activated receptor alpha agonist | 0.057 0.027 CID_69607982 | ||
| 0.211 | 0.14 | 0.211 | 12-Lipoxygenase inhibitor | |||
| 0.076 | 0.005 | 0.076 | Glutamate (mGluR3) antagonist | |||
| 0.09 | 0.019 | 0.09 | Androgen agonist | |||
| 0.133 | 0.063 | 0.133 | Cholinergic antagonist | |||
| 0.075 | 0.004 | 0.075 | Leukotriene B4 receptor 1 antagonist | 0.058 0.005 CID_69607982 | ||
| 0.072 | 0.002 | 0.072 | Estrogen-related receptor gamma antagonist | |||
| 0.073 | 0.003 | 0.073 | Prostaglandin F2 alpha agonist | 0.032 0.008 CID_69607982 | ||
| 0.099 | 0.029 | 0.099 | Caspase 7 inhibitor | |||
| 0.082 | 0.012 | 0.082 | Potassium channel (Inward rectifier) blocker | |||
| 0.09 | 0.02 | 0.09 | Protein kinase C beta inhibitor | 0.069 0.05 CID_69607982 | ||
| 0.079 | 0.009 | 0.079 | Thymidine kinase inhibitor | 0.049 0.019 CID_69607982 | ||
| 0.084 | 0.015 | 0.084 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.091 | 0.021 | 0.091 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.083 | 0.013 | 0.083 | Thromboxane A2 antagonist | |||
| 0.077 | 0.008 | 0.077 | Retinoid X alpha receptor agonist | |||
| 0.073 | 0.004 | 0.073 | Kainate receptor agonist | 0.041 0.029 CID_69607982 | ||
| 0.074 | 0.005 | 0.074 | Retinoic acid alpha receptor agonist | |||
| 0.113 | 0.043 | 0.113 | Nitric-oxide synthase inhibitor | |||
| 0.092 | 0.023 | 0.092 | Ribonucleotide reductase inhibitor | |||
| 0.072 | 0.003 | 0.072 | Toll-Like receptor 8 agonist | |||
| 0.072 | 0.004 | 0.073 | Guanylate cyclase inhibitor | 0.073 0.004 CID_69607982 | CID_69607982 | |
| 0.081 | 0.014 | 0.081 | Calcium channel P-type blocker | |||
| 0.076 | 0.009 | 0.076 | Retinoid X receptor agonist | |||
| 0.083 | 0.016 | 0.083 | Cyclin D1 inhibitor | |||
| 0.079 | 0.012 | 0.079 | Beta 2 adrenoreceptor antagonist | |||
| 0.113 | 0.046 | 0.113 | Potassium channel (Ca-activated) activator | |||
| 0.087 | 0.02 | 0.087 | Potassium channel (Tandem pore domain) blocker | |||
| 0.085 | 0.019 | 0.085 | Exportin-1 inhibitor | |||
| 0.077 | 0.01 | 0.077 | Vanilloid 2 antagonist | |||
| 0.136 | 0.07 | 0.165 | Alkaline phosphatase inhibitor | 0.165 0.051 CID_69607982 | CID_69607982 | |
| 0.069 | 0.004 | 0.069 | Retinoic acid beta receptor agonist | |||
| 0.089 | 0.024 | 0.089 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.132 | 0.069 | 0.132 | NADPH oxidase inhibitor | |||
| 0.076 | 0.012 | 0.076 | Beta 2 adrenoreceptor agonist | |||
| 0.127 | 0.064 | 0.127 | Acetylcholine antagonist | |||
| 0.094 | 0.031 | 0.094 | Cannabinoid receptor antagonist | |||
| 0.067 | 0.004 | 0.067 | Retinoid X receptor antagonist | |||
| 0.073 | 0.01 | 0.073 | Dihydroorotase inhibitor | |||
| 0.092 | 0.03 | 0.092 | Carbonic anhydrase V inhibitor | |||
| 0.101 | 0.039 | 0.101 | Acetylcholine nicotinic antagonist | |||
| 0.142 | 0.081 | 0.142 | MAP kinase 3 inhibitor | |||
| 0.07 | 0.008 | 0.07 | Dopamine D5 agonist | |||
| 0.094 | 0.033 | 0.094 | Acetylcholine M4 receptor antagonist | |||
| 0.085 | 0.024 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.096 | 0.035 | 0.096 | Cathepsin G inhibitor | |||
| 0.078 | 0.017 | 0.078 | Phosphodiesterase 1A inhibitor | |||
| 0.12 | 0.06 | 0.12 | Transcription factor STAT6 inhibitor | |||
| 0.109 | 0.048 | 0.109 | Estrogen receptor beta antagonist | |||
| 0.09 | 0.03 | 0.09 | Carbonic anhydrase VA inhibitor | |||
| 0.065 | 0.005 | 0.065 | Delayed rectifier potassium channel blocker | |||
| 0.084 | 0.024 | 0.084 | Carbonic anhydrase stimulant | |||
| 0.164 | 0.104 | 0.164 | MAP kinase kinase 5 inhibitor | |||
| 0.063 | 0.004 | 0.079 | Ceramide glucosyltransferase inhibitor | 0.079 0.003 CID_69607982 | CID_69607982 | |
| 0.076 | 0.016 | 0.081 | Lipocortins synthesis agonist | 0.081 0.013 CID_69607982 | CID_69607982 | |
| 0.074 | 0.015 | 0.074 | Epithelial sodium channel blocker | |||
| 0.095 | 0.036 | 0.095 | D-Ala-D-Ala ligase inhibitor | |||
| 0.098 | 0.041 | 0.216 | Transcription factor NF kappa B stimulant | 0.216 0.008 CID_69607982 | CID_69607982 | |
| 0.061 | 0.004 | 0.061 | Glutamate (mGluR3) agonist | 0.042 0.008 CID_69607982 | ||
| 0.069 | 0.012 | 0.069 | Immunoglobulin Fc receptor antagonist | |||
| 0.059 | 0.002 | 0.059 | Carbonic anhydrase X inhibitor | |||
| 0.059 | 0.002 | 0.059 | Carbonic anhydrase VIII inhibitor | |||
| 0.066 | 0.01 | 0.066 | Kainate receptor 2 antagonist | |||
| 0.063 | 0.007 | 0.063 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.036 0.014 CID_69607982 | ||
| 0.061 | 0.005 | 0.061 | Melatonin receptor 1A agonist | |||
| 0.061 | 0.005 | 0.061 | Free fatty acid receptor 1 antagonist | |||
| 0.082 | 0.025 | 0.082 | Cannabinoid CB1 receptor antagonist | |||
| 0.078 | 0.022 | 0.078 | Heat shock protein 90 beta antagonist | |||
| 0.062 | 0.006 | 0.062 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.061 | 0.005 | 0.061 | Angiotensin AT1 receptor antagonist | |||
| 0.196 | 0.14 | 0.196 | Transcription factor STAT3 inhibitor | |||
| 0.074 | 0.019 | 0.153 | Carbonic anhydrase XIV inhibitor | 0.153 0.005 CID_69607982 | CID_69607982 | |
| 0.153 | 0.097 | 0.153 | Tumour necrosis factor antagonist | |||
| 0.089 | 0.033 | 0.089 | Epoxide hydrolase inhibitor | |||
| 0.062 | 0.006 | 0.062 | Glutamate (mGluR8) agonist | |||
| 0.069 | 0.014 | 0.069 | Aldosterone antagonist | |||
| 0.06 | 0.006 | 0.06 | Leukotriene C4 antagonist | 0.041 0.023 CID_69607982 | ||
| 0.06 | 0.006 | 0.06 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.059 | 0.005 | 0.059 | Vanilloid 3 antagonist | |||
| 0.065 | 0.01 | 0.065 | GABA B receptor antagonist | |||
| 0.059 | 0.005 | 0.059 | Prostaglandin D2 agonist | 0.03 0.023 CID_69607982 | ||
| 0.095 | 0.041 | 0.095 | Inducible nitric-oxide synthase inhibitor | |||
| 0.11 | 0.056 | 0.11 | Urease inhibitor | |||
| 0.058 | 0.004 | 0.058 | Retinoid X alpha receptor antagonist | |||
| 0.058 | 0.005 | 0.058 | Prostaglandin EP2 agonist | 0.036 0.01 CID_69607982 | ||
| 0.161 | 0.108 | 0.161 | I kappa B kinase epsilon inhibitor | |||
| 0.067 | 0.014 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.066 | 0.013 | 0.066 | Cholesterol esterase inhibitor | 0.047 0.034 CID_69607982 | ||
| 0.079 | 0.026 | 0.079 | NMDA 2C receptor antagonist | |||
| 0.065 | 0.013 | 0.065 | Oxytocin agonist | |||
| 0.078 | 0.025 | 0.078 | Acetylcholine M5 receptor antagonist | |||
| 0.168 | 0.116 | 0.168 | Histone acetyltransferase inhibitor | |||
| 0.074 | 0.023 | 0.074 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.093 | 0.042 | 0.093 | Histamine H2 receptor antagonist | |||
| 0.077 | 0.026 | 0.077 | Cannabinoid CB2 receptor agonist | |||
| 0.178 | 0.128 | 0.55 | Tumour necrosis factor alpha release inhibitor | 0.55 0.01 CID_69607982 | CID_69607982 | |
| 0.068 | 0.018 | 0.113 | Adenine nucleotide translocase inhibitor | 0.113 0.004 CID_69607982 | CID_69607982 | |
| 0.084 | 0.035 | 0.084 | Calcium channel L-type blocker | |||
| 0.068 | 0.019 | 0.068 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.064 | 0.015 | 0.064 | 5-Alpha-reductase inhibitor | |||
| 0.054 | 0.005 | 0.054 | Angiotensin II receptor antagonist | |||
| 0.083 | 0.035 | 0.083 | Amidase inhibitor | |||
| 0.101 | 0.052 | 0.117 | Interleukin 12 antagonist | 0.117 0.032 CID_69607982 | CID_69607982 | |
| 0.072 | 0.024 | 0.072 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.095 | 0.047 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.125 0.016 CID_69607982 | CID_69607982 | |
| 0.082 | 0.034 | 0.082 | Secretase beta inhibitor | |||
| 0.052 | 0.004 | 0.052 | Calcium-independent phospholipase A2 inhibitor | 0.036 0.019 CID_69607982 | ||
| 0.099 | 0.052 | 0.099 | Protein kinase C zeta inhibitor | |||
| 0.068 | 0.021 | 0.068 | Ryanodine receptor antagonist | |||
| 0.066 | 0.02 | 0.066 | Plasminogen activator inhibitor antagonist | |||
| 0.051 | 0.005 | 0.051 | Retinoic acid receptor agonist | |||
| 0.055 | 0.009 | 0.055 | Liver X receptor beta agonist | |||
| 0.073 | 0.028 | 0.073 | Maillard reaction inhibitor | |||
| 0.056 | 0.011 | 0.056 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.113 | 0.068 | 0.202 | Protein-tyrosine phosphatase 1B inhibitor | 0.202 0.029 CID_69607982 | CID_69607982 | |
| 0.051 | 0.006 | 0.135 | Sodium/glucose cotransporter 2 inhibitor | 0.135 0.002 CID_69607982 | CID_69607982 | |
| 0.072 | 0.028 | 0.072 | Phosphodiesterase 1B inhibitor | |||
| 0.074 | 0.03 | 0.077 | Prostaglandin EP2 antagonist | 0.077 0.029 CID_69607982 | CID_69607982 | |
| 0.16 | 0.117 | 0.16 | Anticonvulsant | |||
| 0.062 | 0.019 | 0.062 | Oleamide hydrolase inhibitor | |||
| 0.062 | 0.018 | 0.062 | NMDA receptor subunit 3B antagonist | |||
| 0.055 | 0.012 | 0.055 | Diamine oxidase inhibitor | |||
| 0.046 | 0.004 | 0.046 | Hedgehog signaling activator | |||
| 0.056 | 0.013 | 0.056 | Dihydropteroate synthase inhibitor | |||
| 0.046 | 0.003 | 0.063 | Vanilloid 2 agonist | 0.063 0.002 CID_69607982 | CID_69607982 | |
| 0.045 | 0.003 | 0.045 | Isoleucine-tRNA ligase inhibitor | 0.036 0.004 CID_69607982 | ||
| 0.062 | 0.02 | 0.287 | Heparanase inhibitor | 0.287 0.002 CID_69607982 | CID_69607982 | |
| 0.054 | 0.012 | 0.054 | Nicotinic acid receptor 2 agonist | |||
| 0.044 | 0.003 | 0.044 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 CID_69607982 | ||
| 0.051 | 0.011 | 0.051 | MAP3K5 inhibitor | |||
| 0.056 | 0.016 | 0.056 | Glutamate (mGluR4) antagonist | |||
| 0.045 | 0.005 | 0.045 | Purinergic P2Y15 antagonist | 0.03 0.017 CID_69607982 | ||
| 0.086 | 0.046 | 0.086 | CC chemokine 5 receptor agonist | |||
| 0.044 | 0.004 | 0.044 | DNA polymerase III inhibitor | |||
| 0.051 | 0.011 | 0.051 | Acetylcholine M4 receptor agonist | |||
| 0.042 | 0.003 | 0.042 | Estrogen-related receptor gamma agonist | |||
| 0.055 | 0.016 | 0.055 | Liver X receptor alpha agonist | |||
| 0.062 | 0.022 | 0.062 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.063 | 0.024 | 0.063 | Dihydroorotate oxidase inhibitor | |||
| 0.043 | 0.004 | 0.043 | Nicotinic acid receptor 2 antagonist | |||
| 0.052 | 0.014 | 0.052 | AMPA 4 receptor antagonist | |||
| 0.042 | 0.004 | 0.074 | Ileal bile acid transport inhibitor | 0.074 0.003 CID_69607982 | CID_69607982 | |
| 0.067 | 0.029 | 0.067 | Acetylcholine muscarinic agonist | |||
| 0.058 | 0.02 | 0.058 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.044 | 0.006 | 0.158 | Sodium/glucose cotransporter inhibitor | 0.158 0.002 CID_69607982 | CID_69607982 | |
| 0.19 | 0.153 | 0.19 | Transcription factor STAT inhibitor | |||
| 0.064 | 0.027 | 0.064 | Cyclin B2 inhibitor | |||
| 0.04 | 0.002 | 0.04 | Thromboxane A2 agonist | |||
| 0.044 | 0.007 | 0.044 | Adenosine uptake inhibitor | |||
| 0.069 | 0.033 | 0.069 | Cyclin B1 inhibitor | |||
| 0.043 | 0.007 | 0.043 | Prostaglandin E2 agonist | |||
| 0.051 | 0.015 | 0.051 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.053 | 0.017 | 0.053 | Glutamate (mGluR group III) antagonist | |||
| 0.041 | 0.005 | 0.041 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.045 | 0.009 | 0.045 | Cholesterol ester transfer protein antagonist | |||
| 0.185 | 0.149 | 0.185 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.098 | 0.063 | 0.098 | Glutamate (mGluR7) agonist | |||
| 0.051 | 0.016 | 0.051 | Beta adrenoreceptor agonist | |||
| 0.046 | 0.012 | 0.046 | Peptide deformylase inhibitor | |||
| 0.038 | 0.004 | 0.038 | Acid ceramidase inhibitor | |||
| 0.048 | 0.015 | 0.077 | Squalene synthetase inhibitor | 0.077 0.009 CID_69607982 | CID_69607982 | |
| 0.058 | 0.025 | 0.058 | Bombesin 2 receptor antagonist | |||
| 0.045 | 0.012 | 0.045 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.044 | 0.011 | 0.044 | Liver X receptor beta antagonist | |||
| 0.048 | 0.016 | 0.048 | Heme oxygenase inhibitor | |||
| 0.055 | 0.022 | 0.055 | Thymidylate synthase inhibitor | |||
| 0.077 | 0.044 | 0.077 | Phosphodiesterase V inhibitor | |||
| 0.059 | 0.027 | 0.059 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.058 | 0.027 | 0.058 | H+/K+-transporting ATPase inhibitor | |||
| 0.055 | 0.024 | 0.055 | Dopamine D2 agonist | |||
| 0.036 | 0.004 | 0.036 | G-protein-coupled receptor 120 agonist | |||
| 0.11 | 0.078 | 0.197 | Beta amyloid protein antagonist | 0.197 0.018 CID_69607982 | CID_69607982 | |
| 0.035 | 0.004 | 0.035 | Retinoid X beta receptor antagonist | |||
| 0.066 | 0.035 | 0.066 | Adenosine A1 receptor antagonist | |||
| 0.075 | 0.044 | 0.075 | Phosphodiesterase 5A inhibitor | |||
| 0.042 | 0.011 | 0.042 | Cyclin E2 inhibitor | |||
| 0.054 | 0.023 | 0.054 | Dopamine beta hydroxylase inhibitor | |||
| 0.033 | 0.003 | 0.033 | Thromboxane agonist | |||
| 0.043 | 0.013 | 0.043 | Carnitine palmitoyltransferase inhibitor | |||
| 0.073 | 0.043 | 0.073 | Cyclin B3 inhibitor | |||
| 0.048 | 0.019 | 0.048 | G protein-coupled receptor agonist | |||
| 0.077 | 0.047 | 0.077 | Adenosine A3 receptor antagonist | |||
| 0.049 | 0.02 | 0.049 | NMDA receptor subunit 3A antagonist | |||
| 0.232 | 0.203 | 0.232 | DNA directed DNA polymerase inhibitor | |||
| 0.119 | 0.09 | 0.119 | Cytokine production inhibitor | |||
| 0.046 | 0.018 | 0.046 | Calcitonin receptor agonist | |||
| 0.042 | 0.013 | 0.042 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.04 | 0.011 | 0.04 | Angiotensin AT2 receptor antagonist | |||
| 0.05 | 0.021 | 0.05 | Kainate receptor antagonist | |||
| 0.035 | 0.006 | 0.035 | Glucosylceramidase stimulant | |||
| 0.056 | 0.027 | 0.056 | Metalloproteinase-3 inhibitor | |||
| 0.032 | 0.004 | 0.032 | Vitamin D receptor agonist | 0.027 0.004 CID_69607982 | ||
| 0.055 | 0.027 | 0.055 | Potassium channel (Inward rectifier) activator | |||
| 0.071 | 0.043 | 0.071 | Matrix metalloproteinase inhibitor | |||
| 0.032 | 0.004 | 0.032 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.038 | 0.011 | 0.038 | Lysine carboxypeptidase inhibitor | |||
| 0.052 | 0.026 | 0.052 | Potassium channel (ATP-sensitive) activator | |||
| 0.047 | 0.021 | 0.047 | Plasmepsin II inhibitor | |||
| 0.032 | 0.005 | 0.032 | Retinoic acid gamma receptor agonist | |||
| 0.033 | 0.007 | 0.044 | Leukotriene B4 receptor 2 antagonist | 0.044 0.005 CID_69607982 | CID_69607982 | |
| 0.063 | 0.037 | 0.063 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.063 0.036 CID_69607982 | ||
| 0.051 | 0.025 | 0.051 | Acetylcholine M1 receptor agonist | |||
| 0.032 | 0.006 | 0.032 | Vitamin D receptor antagonist | 0.023 0.013 CID_69607982 | ||
| 0.031 | 0.006 | 0.031 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.039 | 0.014 | 0.039 | ATP citrate lysase inhibitor | |||
| 0.055 | 0.03 | 0.055 | Prolyl endopeptidase inhibitor | |||
| 0.036 | 0.011 | 0.036 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.034 | 0.009 | 0.034 | Thyroid hormone agonist | |||
| 0.044 | 0.019 | 0.044 | Farnesoid X receptor agonist | |||
| 0.048 | 0.024 | 0.048 | Histamine H2 receptor agonist | |||
| 0.07 | 0.045 | 0.07 | Neuronal nicotinic receptor antagonist | |||
| 0.096 | 0.072 | 0.098 | Folate antagonist | 0.098 0.068 CID_69607982 | CID_69607982 | |
| 0.041 | 0.017 | 0.041 | Prostacyclin antagonist | |||
| 0.04 | 0.016 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.06 | 0.036 | 0.06 | Fatty acid synthase inhibitor | |||
| 0.085 | 0.061 | 0.085 | Hematopoietic | |||
| 0.033 | 0.01 | 0.033 | Prostaglandin H2 antagonist | |||
| 0.034 | 0.011 | 0.034 | LFA antagonist | |||
| 0.032 | 0.01 | 0.032 | Thymidine phosphorylase inhibitor | |||
| 0.052 | 0.03 | 0.052 | HCV NS3/NS4A protease inhibitor | |||
| 0.032 | 0.01 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.005 CID_69607982 | CID_69607982 | |
| 0.026 | 0.004 | 0.035 | Telomerase stimulant | 0.035 0.002 CID_69607982 | CID_69607982 | |
| 0.057 | 0.035 | 0.057 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.033 | 0.012 | 0.033 | Dopamine autoreceptor agonist | |||
| 0.056 | 0.035 | 0.056 | Matrix metalloproteinase 1 inhibitor | |||
| 0.046 | 0.025 | 0.046 | Dihydrofolate reductase inhibitor | |||
| 0.065 | 0.045 | 0.065 | Neutrophil collagenase inhibitor | |||
| 0.057 | 0.036 | 0.057 | Phosphodiesterase II inhibitor | |||
| 0.065 | 0.045 | 0.065 | Dopamine D1 antagonist | |||
| 0.048 | 0.027 | 0.048 | Phosphodiesterase 6C inhibitor | |||
| 0.037 | 0.017 | 0.037 | Carboxypeptidase B inhibitor | |||
| 0.038 | 0.018 | 0.038 | Melatonin 2 agonist | 0.03 0.027 CID_69607982 | ||
| 0.025 | 0.005 | 0.025 | Thyroid hormone alpha antagonist | |||
| 0.056 | 0.036 | 0.056 | Cyclin B inhibitor | |||
| 0.029 | 0.009 | 0.029 | 5-Alpha-reductase 2 inhibitor | |||
| 0.037 | 0.018 | 0.037 | Melatonin 1 agonist | |||
| 0.042 | 0.023 | 0.042 | Vascular adhesion protein 1 inhibitor | |||
| 0.023 | 0.004 | 0.023 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.024 | 0.005 | 0.049 | Antibiotic Anthracycline-like | 0.049 0.002 CID_69607982 | CID_69607982 | |
| 0.023 | 0.005 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 CID_69607982 | ||
| 0.03 | 0.012 | 0.03 | Retinoid X gamma receptor antagonist | |||
| 0.038 | 0.019 | 0.038 | Sirtuin 2 inhibitor | |||
| 0.139 | 0.121 | 0.139 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.067 | 0.049 | 0.067 | Protein kinase C alpha inhibitor | |||
| 0.03 | 0.012 | 0.057 | Toll-Like receptor 4 agonist | 0.057 0.003 CID_69607982 | CID_69607982 | |
| 0.039 | 0.021 | 0.039 | p53 inhibitor | |||
| 0.059 | 0.042 | 0.059 | Collagenase 3 inhibitor | |||
| 0.022 | 0.006 | 0.022 | Purinergic P2Y1 agonist | 0.017 0.009 CID_69607982 | ||
| 0.034 | 0.019 | 0.034 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.026 | 0.01 | 0.026 | ICAM 1 antagonist | |||
| 0.095 | 0.079 | 0.264 | Beta glucuronidase inhibitor | 0.264 0.008 CID_69607982 | CID_69607982 | |
| 0.05 | 0.034 | 0.05 | Factor III inhibitor | 0.049 0.038 CID_69607982 | ||
| 0.044 | 0.029 | 0.044 | Liver X receptor agonist | |||
| 0.03 | 0.014 | 0.03 | CXC chemokine 2 receptor antagonist | |||
| 0.019 | 0.004 | 0.019 | Carbonic anhydrase XI inhibitor | |||
| 0.057 | 0.042 | 0.057 | Cathepsin L inhibitor | |||
| 0.025 | 0.01 | 0.025 | Angiotensin AT1A receptor antagonist | |||
| 0.03 | 0.015 | 0.03 | Leukotriene D4 antagonist | 0.023 0.022 CID_69607982 | ||
| 0.019 | 0.004 | 0.019 | Cyclin D2 inhibitor | |||
| 0.052 | 0.037 | 0.052 | Autotaxin inhibitor | |||
| 0.125 | 0.111 | 0.125 | Neuropeptide Y1 antagonist | |||
| 0.026 | 0.012 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.024 | 0.01 | 0.024 | 5-Alpha-reductase 1 inhibitor | |||
| 0.019 | 0.004 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.02 | 0.006 | 0.02 | Angiotensin AT1B receptor antagonist | |||
| 0.047 | 0.033 | 0.047 | Benzodiazepine antagonist | |||
| 0.021 | 0.008 | 0.021 | Nicotinic acid receptor 1 antagonist | |||
| 0.026 | 0.013 | 0.026 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.018 | 0.004 | 0.018 | DNA polymerase III polC-type inhibitor | |||
| 0.021 | 0.008 | 0.021 | Prostaglandin EP4 agonist | |||
| 0.022 | 0.009 | 0.022 | Retinoic acid receptor antagonist | |||
| 0.046 | 0.034 | 0.046 | CC chemokine 4 receptor antagonist | |||
| 0.035 | 0.023 | 0.035 | HMG CoA reductase inhibitor | 0.033 0.027 CID_69607982 | ||
| 0.057 | 0.045 | 0.057 | Acetylcholine M3 receptor antagonist | |||
| 0.078 | 0.066 | 0.078 | Thioredoxin reductase inhibitor | |||
| 0.045 | 0.033 | 0.102 | Phosphorylase inhibitor | 0.102 0.013 CID_69607982 | CID_69607982 | |
| 0.038 | 0.027 | 0.038 | Glutamate (mGluR group II) antagonist | |||
| 0.02 | 0.008 | 0.02 | Prostacyclin agonist | |||
| 0.082 | 0.071 | 0.082 | Bromodomain-containing protein 2 inhibitor | |||
| 0.048 | 0.037 | 0.048 | Phosphodiesterase 2A inhibitor | |||
| 0.042 | 0.031 | 0.042 | Leukocyte elastase inhibitor | |||
| 0.056 | 0.046 | 0.056 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.015 | 0.004 | 0.015 | Angiotensin AT2 receptor agonist | |||
| 0.052 | 0.041 | 0.089 | Protein kinase C eta inhibitor | 0.089 0.02 CID_69607982 | CID_69607982 | |
| 0.065 | 0.055 | 0.065 | Prostaglandin-E synthase inhibitor | |||
| 0.15 | 0.14 | 0.15 | Growth factor agonist | |||
| 0.021 | 0.011 | 0.021 | Follicle-stimulating hormone antagonist | |||
| 0.038 | 0.028 | 0.038 | Alpha 1d adrenoreceptor agonist | |||
| 0.023 | 0.014 | 0.023 | Follicle-stimulating hormone agonist | |||
| 0.068 | 0.059 | 0.068 | Metalloproteinase-9 inhibitor | |||
| 0.015 | 0.006 | 0.015 | Glutamate (mGluR6) agonist | |||
| 0.021 | 0.013 | 0.021 | Retinoic acid alpha receptor antagonist | |||
| 0.012 | 0.004 | 0.012 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.027 | 0.018 | 0.027 | Myristoyl transferase inhibitor | |||
| 0.024 | 0.015 | 0.024 | Phosphodiesterase 6A inhibitor | |||
| 0.03 | 0.022 | 0.03 | Epoxide hydrolase 1 inhibitor | |||
| 0.099 | 0.091 | 0.444 | Cell adhesion inhibitor | 0.444 0.005 CID_69607982 | CID_69607982 | |
| 0.018 | 0.009 | 0.018 | Adenosine A2 receptor agonist | 0.015 0.013 CID_69607982 | ||
| 0.056 | 0.048 | 0.056 | Acetylcholine M2 receptor antagonist | |||
| 0.051 | 0.043 | 0.051 | GABA receptor antagonist | |||
| 0.024 | 0.017 | 0.024 | 5 Hydroxytryptamine 4 agonist | |||
| 0.042 | 0.034 | 0.042 | Histamine H1 receptor agonist | |||
| 0.036 | 0.028 | 0.036 | Factor XIIIa inhibitor | |||
| 0.035 | 0.027 | 0.035 | Glutamate (mGluR8) antagonist | |||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | |||
| 0.025 | 0.019 | 0.025 | Prostaglandin EP4 antagonist | |||
| 0.071 | 0.064 | 0.071 | Metalloproteinase-2 inhibitor | |||
| 0.076 | 0.07 | 0.076 | NMDA receptor antagonist | |||
| 0.013 | 0.007 | 0.013 | Purine nucleoside phosphorylase inhibitor | |||
| 0.009 | 0.004 | 0.009 | DNA polymerase III subunit alpha inhibitor | |||
| 0.021 | 0.015 | 0.021 | Kainate receptor 1 antagonist | |||
| 0.022 | 0.016 | 0.022 | Beta 1 adrenoreceptor agonist | |||
| 0.062 | 0.056 | 0.062 | Sirtuin 1 inhibitor | |||
| 0.018 | 0.013 | 0.018 | Cyclin T1 inhibitor | |||
| 0.028 | 0.022 | 0.028 | Glucagon receptor antagonist | |||
| 0.018 | 0.013 | 0.018 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.044 | 0.039 | 0.055 | Estrogen agonist | 0.055 0.033 CID_69607982 | CID_69607982 | |
| 0.015 | 0.01 | 0.015 | Adenosine A2a receptor agonist | |||
| 0.076 | 0.071 | 0.076 | Acetylcholine agonist | |||
| 0.016 | 0.012 | 0.016 | Nicotinic alpha4 receptor agonist | |||
| 0.068 | 0.065 | 0.068 | Glutamate receptor agonist | |||
| 0.03 | 0.027 | 0.03 | Melatonin agonist | |||
| 0.009 | 0.006 | 0.009 | Corticotropin releasing factor antagonist | |||
| 0.027 | 0.023 | 0.027 | AMPA 3 receptor antagonist | |||
| 0.124 | 0.121 | 0.124 | Heat shock protein 90 alpha antagonist | |||
| 0.043 | 0.039 | 0.043 | Parathyroid hormone antagonist | |||
| 0.026 | 0.023 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.036 | 0.033 | 0.036 | Histone deacetylase 9 inhibitor | |||
| 0.038 | 0.035 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.058 | 0.055 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.02 | 0.018 | 0.02 | Geranylgeranyltransferase inhibitor | |||
| 0.018 | 0.015 | 0.018 | Alpha 2b adrenoreceptor agonist | |||
| 0.037 | 0.034 | 0.037 | CDK5/p25 inhibitor | |||
| 0.004 | 0.003 | 0.004 | Reverse transcriptase (HBV) inhibitor | |||
| 0.033 | 0.032 | 0.033 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.047 | 0.046 | 0.047 | GABA A receptor antagonist | |||
| 0.046 | 0.045 | 0.046 | CD45 antagonist | |||
| 0.036 | 0.035 | 0.036 | 5 Hydroxytryptamine 2B agonist | |||
| 0.009 | 0.011 | 0.012 | Purinergic P2Y2 agonist | 0.012 0.005 CID_69607982 | CID_69607982 | |
| 0.018 | 0.02 | 0.03 | Corticosteroid-like | 0.03 0.007 CID_69607982 | CID_69607982 | |
| 0.032 | 0.034 | 0.09 | Antibiotic Aminoglycoside-like | 0.09 0.004 CID_69607982 | CID_69607982 | |
| 0.051 | 0.054 | 0.059 | Carbonic anhydrase inhibitor | 0.059 0.047 CID_69607982 | CID_69607982 | |
| 0.061 | 0.072 | 0.261 | Antineoplastic antibiotic | 0.261 0.013 CID_69607982 | CID_69607982 | |
| 0.058 | 0.078 | 0.201 | Topoisomerase II alpha inhibitor | 0.201 0.015 CID_69607982 | CID_69607982 | |
| 0.064 | 0.085 | 0.318 | Cell adhesion molecule inhibitor | 0.318 0.005 CID_69607982 | CID_69607982 | |
| 0.026 | 0.062 | 0.079 | Carbonic anhydrase XII inhibitor | 0.079 0.026 CID_69607982 | CID_69607982 | |
| 0.008 | 0.05 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.012 CID_69607982 | CID_69607982 | |
| 0.03 | 0.073 | 0.06 | Microtubule stabilization | 0.06 0.015 CID_69607982 | CID_69607982 | |
| 0.024 | 0.069 | 0.058 | Carbonic anhydrase IX inhibitor | 0.058 0.038 CID_69607982 | CID_69607982 | |
| 0.187 | 0.232 | 0.512 | Alpha-glucosidase inhibitor | 0.512 0.077 CID_69607982 | CID_69607982 | |
| 0.003 | 0.051 | 0.018 | Antibiotic Macrolide-like | 0.018 0.007 CID_69607982 | CID_69607982 | |
| 0.013 | 0.066 | 0.072 | Protein 30S ribosomal subunit inhibitor | 0.072 0.005 CID_69607982 | CID_69607982 | |
| 0.058 | 0.123 | 0.304 | Topoisomerase I inhibitor | 0.304 0.01 CID_69607982 | CID_69607982 | |
| 0.023 | 0.092 | 0.038 | Protein kinase C beta I inhibitor | 0.038 0.011 CID_69607982 | CID_69607982 | |
| 0.027 | 0.095 | 0.137 | Protein 50S ribosomal subunit inhibitor | 0.137 0.008 CID_69607982 | CID_69607982 | |
| 0.008 | 0.104 | 0.022 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.022 0.005 CID_69607982 | CID_69607982 | |
| 0.018 | 0.127 | 0.06 | Aldose reductase inhibitor | 0.06 0.032 CID_69607982 | CID_69607982 | |
| 0.156 | 0.266 | 0.265 | Antiobesity | 0.265 0.143 CID_69607982 | CID_69607982 | |
| 0.051 | 0.172 | 0.123 | DNA intercalator | 0.123 0.056 CID_69607982 | CID_69607982 | |
| 0.045 | 0.19 | 0.258 | Topoisomerase II inhibitor | 0.258 0.023 CID_69607982 | CID_69607982 | |
| 0.141 | 0.302 | 0.338 | Caspase 3 stimulant | 0.338 0.063 CID_69607982 | CID_69607982 | |
| 0.061 | 0.248 | 0.316 | Anticoagulant | 0.316 0.026 CID_69607982 | CID_69607982 | |
| 0.007 | 0.207 | 0.021 | Motilin receptor agonist | 0.021 0.019 CID_69607982 | CID_69607982 | |
| 0.021 | 0.26 | 0.097 | Glucose-6-phosphate translocase inhibitor | 0.097 0.007 CID_69607982 | CID_69607982 | |
| 0.025 | 0.29 | 0.066 | Histone deacetylase stimulant | 0.066 0.061 CID_69607982 | CID_69607982 | |
| 0.025 | 0.29 | 0.066 | Histone deacetylase SIRT1 stimulant | 0.066 0.061 CID_69607982 | CID_69607982 | |
| 0.018 | 0.429 | 0.1 | Factor IXa inhibitor | 0.1 0.01 CID_69607982 | CID_69607982 | |
| 0.023 | 0.448 | 0.145 | Multidrug resistance-associated protein 1 inhibitor | 0.145 0.028 CID_69607982 | CID_69607982 | |
| 0.082 | 0.514 | 0.151 | CC chemokine 6 receptor antagonist | 0.151 0.02 CID_69607982 | CID_69607982 | |
| 0.05 | 0.489 | 0.266 | Angiogenesis inhibitor | 0.266 0.112 CID_69607982 | CID_69607982 | |
| 0.035 | 0.649 | 0.348 | NOS3 expression enhancer | 0.348 0.012 CID_69607982 | CID_69607982 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |